KK, M., Z, S., R, S., MK, B., AT, D., O, E., . . . MR, P. (2023). Synthesis of New Shogaol Analogues as NRF2 Activators and Evaluation of Their Anti-Inflammatory Activity, Modes of Action and Metabolic Stability. Antioxidants (Basel, Switzerland), 12(2), . https://doi.org/10.3390/antiox12020475
Chicago Style (17th ed.) CitationKK, Mak, Shiming Z, Sakirolla R, Balijepalli MK, Dinkova-Kostova AT, Epemolu O, Mohd Z, and Pichika MR. "Synthesis of New Shogaol Analogues as NRF2 Activators and Evaluation of Their Anti-Inflammatory Activity, Modes of Action and Metabolic Stability." Antioxidants (Basel, Switzerland) 12, no. 2 (2023). https://doi.org/10.3390/antiox12020475.
MLA (9th ed.) CitationKK, Mak, et al. "Synthesis of New Shogaol Analogues as NRF2 Activators and Evaluation of Their Anti-Inflammatory Activity, Modes of Action and Metabolic Stability." Antioxidants (Basel, Switzerland), vol. 12, no. 2, 2023, https://doi.org/10.3390/antiox12020475.
